PRECIGEN, INC.

PRECIGEN, INC. (ticker: PGEN) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of PGEN's SEC filings surfaces 4 active risk signals, including 2 auditor-change signals, 1 delisting/deregistration signal, and 1 late-filing signal. PGEN reported $23.25M in revenue and -$7.93M for the period ending 2026-03-31, with operating cash flow of -$43.83M. Cash and equivalents stood at $7.48M (up 23.5% year-over-year). Total assets of $138.63M exceed total liabilities of $118.39M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.